Geneva Advisors’s General Moly, Inc. GMO Stock Holding History

Geneva Advisors’s Portfolio GMO Stock Details GMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$5K	Hold	13,518	–	–	﹤0.01%	733
2017 Q1	$7K	Hold	13,518	–	–	﹤0.01%	759
2016 Q4	$3K	Hold	13,518	–	–	﹤0.01%	762
2016 Q3	$4K	Hold	13,518	–	–	﹤0.01%	746
2016 Q2	$5K	Hold	13,518	–	–	﹤0.01%	704
2016 Q1	$5K	Hold	13,518	–	–	﹤0.01%	699
2015 Q4	$3K	Hold	13,518	–	–	﹤0.01%	655
2015 Q3	$4K	Hold	13,518	–	–	﹤0.01%	630
2015 Q2	$10K	Hold	13,518	–	–	﹤0.01%	678
2015 Q1	$7K	Hold	13,518	–	–	﹤0.01%	673
2014 Q4	$8K	Hold	13,518	–	–	﹤0.01%	689
2014 Q3	$10K	Hold	13,518	–	–	﹤0.01%	681
2014 Q2	$16K	Hold	13,518	–	–	﹤0.01%	685
2014 Q1	$13K	Hold	13,518	–	–	﹤0.01%	663
2013 Q4	$18K	Hold	13,518	–	–	﹤0.01%	552
2013 Q3	$22K	Hold	13,518	–	–	﹤0.01%	499
2013 Q2	$25K	Buy	+13,518	New	+$26.6K	﹤0.01%	429

Other funds holding GMO

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIM

Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

Evanston Advisors Schaumburg, Illinois $368M AUM 7.83% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geneva Advisors's GMO Position: Q2 2017 in Review

Geneva Advisors held its General Moly, Inc. (GMO) position steady in Q2 2017 at 13,518 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Geneva Advisors first reported a position in GMO in Q2 2013 and has held it in 17 quarters since. The position peaked at $25K in Q2 2013. 39 funds tracked by Wall St. Rank hold GMO as of Q2 2017.

Geneva Advisors held 13,518 shares of General Moly, Inc. worth $5K as of Q2 2017.
Geneva Advisors left its General Moly, Inc. share count unchanged in Q2 2017.
General Moly, Inc. made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #733 holding.
Geneva Advisors first reported a position in General Moly, Inc. in Q2 2013 and has held it in 17 quarters since.
Geneva Advisors's General Moly, Inc. position peaked at $25K in Q2 2013.
39 funds tracked by Wall St. Rank held General Moly, Inc. as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.